Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures
Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
Aim: To compare the postoperative outcomes after surgical infiltration with plain bupivacaine
compared to liposomal bupivacaine in patients undergoing elective, minimally invasive,
general surgery procedures. To the investigators knowledge, there are no head-to-head,
prospective, randomized, controlled trials of plain bupivacaine versus liposomal bupivacaine
to evaluate postoperative pain and return of function.